Sarah Cannon, Redefining Cancer Care Across HCA
Together with Sarah Cannon, the global cancer institute of Hospital Corporation of America (HCA), we offer integrated cancer services with convenient access to cutting-edge therapies for those facing cancer in our community. Recognized as leaders in cancer care, our experts use the latest research and technology to provide you with the best treatment at the right time in your cancer journey.
The research arm of Sarah Cannon, Sarah Cannon Research Institute, was formed more than 20 years ago to ensure patients could access cutting-edge therapies closer to home. In partnering with leading pharmaceutical/biotech companies and investigators, Sarah Cannon treats approximately 2,500 patients each year on clinical trials across the U.S. & UK.
Across its global network, Sarah Cannon is providing state-of-the-art cancer care close to home for hundreds of thousands of patients, a number unmatched by any single cancer center. To learn more about Sarah Cannon, visit sarahcannon.com.
Sarah Cannon Cancer Institute at HCA Midwest Health offers access to novel therapies through clinical trials and is providing state-of-the-art cancer care close to home for hundreds of thousands of patients, a number unmatched by any single cancer center.
The Sarah Cannon Cancer Institute at HCA Midwest Health is a network of hospitals and physicians that brings together the expertise and technology to provide patients throughout our region with a new level of care and support as they face cancer. Our physicians are board-certified in medical oncology, radiation oncology and specialties such as gynecologic oncology and surgery. Our nursing and health staff is comprised of skilled, experienced cancer practitioners.
The Sarah Cannon Cancer Institute is anchored by the comprehensive cancer programs at Menorah Medical Center and Research Medical Center. Both are accredited by the American College of Surgeons’ Commission on Cancer as Community Hospital Comprehensive Cancer Programs. In addition, Centerpoint Medical Center is an accredited Community Hospital Cancer Program and Belton Regional Medical Center is an accredited Associate Cancer Program. All strive to exceed national oncology standards.
Sarah Cannon Cancer Institute offers a comprehensive range of testing and treatment options, such as inpatient cancer services with a dedicated leukemia/lymphoma unit, surgical services, unparalleled radiation oncology services, and outpatient chemotherapy facilities. Patient navigators and nurse educators are available to help guide patients through their cancer journey from diagnosis through recovery. Additionally, Sarah Cannon Cancer Institute at HCA Midwest Health offers genetic counseling and specialized treatments such as lymphedema therapy.
Through our physician-led governance and patient-centered care model, Sarah Cannon Cancer Institute is driving quality standards and program development. Our recognized physician leadership is embracing new standards of cancer care based on the latest research including the development and implementation of novel targeted therapies, as well as personalized medicine capabilities such as molecular profiling, which tailors treatment plans to the genetic profile of the patient's cancer.
Our established workgroups are organized by disease-site specific cancer programs including breast, complex GI, thoracic, gyn oncology, radiation oncology, and managed by a multidisciplinary team of engaged cancer specialists. Our tumor and market conferences connect physicians across the HCA Midwest Health and coordinate optimum patient treatment plans.
Sarah Cannon Cancer Institute also offers cancer support, screening and education programs for patients and families.